Satellos Bioscience Inc. GAAP EPS of -$0.03

Published 2 months ago • Aug 13, 2025 at 1:46 PM • Positive

* Satellos Bioscience Inc. press release [https://seekingalpha.com/pr/20199074-satellos-reports-second-quarter-2025-results-and-highlights-upcoming-clinical-milestones] (TSX:MSCL:CA [https://seekingalpha.com/symbol/MSCL:CA]): Q2 GAAP EPS of -$0.03.

MORE ON SATELLOS BIOSCIENCE INC.

* Historical earnings data for Satellos Bioscience Inc. [https://seekingalpha.com/symbol/MSCL:CA/earnings]
* Financial information for Satellos Bioscience Inc. [https://seekingalpha.com/symbol/MSCL:CA/income-statement]

Menu

Satellos Bioscience Inc. GAAP EPS of -$0.03

Related Stocks

More News

Leishen Energy(LSE) Makes a Strong Debut at ADIPEC Abu Dhabi, Embarking on a New Chapter of Strategic Expansion in the Middle East and International Markets

Startups from Australia, India and UAE crowned winners in L'Oréal Groupe's biggest Beauty Tech competition across South Asia Pacific, Middle East and North Africa

Kirin: Development of a Fermented Ingredient Derived from Coffee Cherries to Enhance Body and Aroma Contributing to the Sustainability of Coffee Farms, Reduction of Environmental Impact, and Addressing Alcohol-related Social Issues

ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK

FLY Investor News: If You Have Suffered Losses in Firefly Aerospace Inc. (NASDAQ: FLY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights